FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2770707913> ?p ?o ?g. }

• W2770707913 abstract "Beneficial effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) against recurrent colorectal adenomas have been documented in systematic reviews; however, the results have not been conclusive. Uncertainty remains about the appropriate dose of aspirin for adenoma prevention. The persistence of the protective effect of NSAIDs against recurrent adenomas after treatment cessation is yet to be established.Our objective was to update and systematically evaluate the evidence for aspirin and other NSAIDs on the incidence of recurrent colorectal adenomas taking into consideration the risks of random error and to appraise the quality of evidence using GRADE (The Grading of Recommendations, Assessment, Development and Evaluation) approach. Retrieved trials were evaluated using Cochrane risk of bias instrument. Meta-analytic estimates were calculated with random-effects model and random errors were evaluated with trial sequential analysis (TSA).In patients with a previous history of colorectal cancer or adenomas, low-dose aspirin (80-160 mg/day) compared to placebo taken for 2 to 4 years reduces the risk of recurrent colorectal adenomas (relative risk (RR), 0.80 [95% CI (confidence interval), 0.70-0.92]). TSA indicated a firm evidence for this beneficial effect. The evidence indicated moderate GRADE quality. Low-dose aspirin also reduces the recurrence of advanced adenomas (RR, 0.66 [95% CI, 0.44-0.99]); however, TSA indicated lack of firm evidence for a beneficial effect. High-dose aspirin (300-325 mg/day) did not statistically reduce the recurrent adenomas (RR, 0.90 [95% CI, 0.68-1.18]). Cyclooxygenase-2 (COX-2) inhibitors (e.g. celecoxib 400 mg/day) were associated with a significant decrease in the recurrence of both adenomas (RR, 0.66 [95% CI, 0.59-0.72]) and advanced adenomas (RR, 0.45 [95% CI, 0.33-0.57]); however, this association did not persist and there was a trend of an increased risk of recurrent adenomas observed 2 years after the withdrawal.Our findings confirm the beneficial effect of low-dose aspirin on recurrence of any adenomas; however, effect on advanced adenomas was inconclusive. COX-2 inhibitors seem to be more effective in preventing recurrence of adenomas; however, there was a trend of an increased risk of recurrence of adenomas observed after discontinuing regular use." @default.
• W2770707913 created "2017-12-04" @default.
• W2770707913 creator A5013349830 @default.
• W2770707913 creator A5014149389 @default.
• W2770707913 creator A5021457387 @default.
• W2770707913 creator A5058993607 @default.
• W2770707913 creator A5062702667 @default.
• W2770707913 creator A5090226695 @default.
• W2770707913 date "2017-11-14" @default.
• W2770707913 modified "2023-10-11" @default.
• W2770707913 title "Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials" @default.
• W2770707913 cites W1247968195 @default.
• W2770707913 cites W1480729244 @default.
• W2770707913 cites W1526269920 @default.
• W2770707913 cites W1554678066 @default.
• W2770707913 cites W1572120776 @default.
• W2770707913 cites W1945695150 @default.
• W2770707913 cites W1967447048 @default.
• W2770707913 cites W1971441597 @default.
• W2770707913 cites W1975076018 @default.
• W2770707913 cites W1980256331 @default.
• W2770707913 cites W1982248155 @default.
• W2770707913 cites W1984387799 @default.
• W2770707913 cites W1985159759 @default.
• W2770707913 cites W1987698903 @default.
• W2770707913 cites W2005501262 @default.
• W2770707913 cites W2024233889 @default.
• W2770707913 cites W2024352468 @default.
• W2770707913 cites W2025039880 @default.
• W2770707913 cites W2028338557 @default.
• W2770707913 cites W2036774104 @default.
• W2770707913 cites W2054883739 @default.
• W2770707913 cites W2063675387 @default.
• W2770707913 cites W2067377514 @default.
• W2770707913 cites W2072644977 @default.
• W2770707913 cites W2073636239 @default.
• W2770707913 cites W2078388299 @default.
• W2770707913 cites W2081246578 @default.
• W2770707913 cites W2087224686 @default.
• W2770707913 cites W2095127972 @default.
• W2770707913 cites W2095769165 @default.
• W2770707913 cites W2097235831 @default.
• W2770707913 cites W2097903769 @default.
• W2770707913 cites W2098923148 @default.
• W2770707913 cites W2101463209 @default.
• W2770707913 cites W2102937816 @default.
• W2770707913 cites W2107534719 @default.
• W2770707913 cites W2107981193 @default.
• W2770707913 cites W2119605658 @default.
• W2770707913 cites W2122411706 @default.
• W2770707913 cites W2123411656 @default.
• W2770707913 cites W2134234269 @default.
• W2770707913 cites W2135393211 @default.
• W2770707913 cites W2137520566 @default.
• W2770707913 cites W2138188443 @default.
• W2770707913 cites W2147339810 @default.
• W2770707913 cites W2148012410 @default.
• W2770707913 cites W2151849899 @default.
• W2770707913 cites W2153551773 @default.
• W2770707913 cites W2157823046 @default.
• W2770707913 cites W2160901667 @default.
• W2770707913 cites W2163222581 @default.
• W2770707913 cites W2165010366 @default.
• W2770707913 cites W2171956877 @default.
• W2770707913 cites W2193732131 @default.
• W2770707913 cites W2331422116 @default.
• W2770707913 cites W2397606686 @default.
• W2770707913 cites W2469665098 @default.
• W2770707913 cites W2588681363 @default.
• W2770707913 cites W4239558974 @default.
• W2770707913 cites W4253462034 @default.
• W2770707913 doi "https://doi.org/10.1186/s12885-017-3757-8" @default.
• W2770707913 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5686945" @default.
• W2770707913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29137605" @default.
• W2770707913 hasPublicationYear "2017" @default.
• W2770707913 type Work @default.
• W2770707913 sameAs 2770707913 @default.
• W2770707913 citedByCount "63" @default.
• W2770707913 countsByYear W27707079132018 @default.
• W2770707913 countsByYear W27707079132019 @default.
• W2770707913 countsByYear W27707079132020 @default.
• W2770707913 countsByYear W27707079132021 @default.
• W2770707913 countsByYear W27707079132022 @default.
• W2770707913 countsByYear W27707079132023 @default.
• W2770707913 crossrefType "journal-article" @default.
• W2770707913 hasAuthorship W2770707913A5013349830 @default.
• W2770707913 hasAuthorship W2770707913A5014149389 @default.
• W2770707913 hasAuthorship W2770707913A5021457387 @default.
• W2770707913 hasAuthorship W2770707913A5058993607 @default.
• W2770707913 hasAuthorship W2770707913A5062702667 @default.
• W2770707913 hasAuthorship W2770707913A5090226695 @default.
• W2770707913 hasBestOaLocation W27707079131 @default.
• W2770707913 hasConcept C120665830 @default.
• W2770707913 hasConcept C121332964 @default.
• W2770707913 hasConcept C121608353 @default.
• W2770707913 hasConcept C126322002 @default.
• W2770707913 hasConcept C127413603 @default.
• W2770707913 hasConcept C142724271 @default.
• W2770707913 hasConcept C147176958 @default.
• W2770707913 hasConcept C168563851 @default.

• next